Clinical trial
An Open-Label, Comparative Study of Immediate or Delayed Switch to Paliperidone Palmitate in Patients Unsatisfied With Current Oral Atypical Antipsychotics to Evaluate the Evolution of Medication Satisfaction and Adherence
NCT01682161 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Comparative Study of Immediate or Delayed Switch to Paliperidone Palmitate in Patients Unsatisfied With Current Oral Atypical Antipsychotics to Evaluate the Evolution of Medication Satisfaction and Adherence
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- September 30, 2013
- Enrollment
- 154 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.